University of Naples Federico II-ko ikertzaileekin lankidetzan egindako argitalpenak (16)

2023

  1. Applied coronary physiology for planning and guidance of percutaneous coronary interventions. A clinical consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the European Society of Cardiology

    EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, Vol. 19, Núm. 6, pp. 464-481

  2. Biolimus-eluting vs. other limus-eluting stents in NSTE-ACS: A pooled analysis of GLASSY and TWILIGHT

    International Journal of Cardiology, Vol. 383, pp. 24-32

  3. Impact of Age at the Time of the First ST-Elevation Myocardial Infarction on 10-Year Outcomes (from the EXAMINATION-EXTEND Trial)

    American Journal of Cardiology, Vol. 190, pp. 32-40

  4. Impact of Post-PCI FFR Stratified by Coronary Artery

    JACC: Cardiovascular Interventions, Vol. 16, Núm. 19, pp. 2396-2408

  5. Rationale and design of the pullback pressure gradient (PPG) global registry

    American Heart Journal, Vol. 265, pp. 170-179

  6. Stroke volume index and transvalvular flow rate trajectories in severe aortic stenosis treated with TAVR

    European Heart Journal Cardiovascular Imaging, Vol. 24, Núm. 8, pp. 1052-1061

2022

  1. Impact of Diabetes on 10-Year Outcomes Following ST-Segment–Elevation Myocardial Infarction: Insights From the EXAMINATION-EXTEND Trial

    Journal of the American Heart Association, Vol. 11, Núm. 23

  2. Sex Differences in 10-Year Outcomes Following STEMI: A Subanalysis From the EXAMINATION-EXTEND Trial

    JACC: Cardiovascular Interventions, Vol. 15, Núm. 19, pp. 1965-1973

2021

  1. Invasive Coronary Physiology After Stent Implantation: Another Step Toward Precision Medicine

    JACC: Cardiovascular Interventions, Vol. 14, Núm. 3, pp. 237-246

  2. Ticagrelor Monotherapy Versus Dual-Antiplatelet Therapy After PCI: An Individual Patient-Level Meta-Analysis

    JACC: Cardiovascular Interventions, Vol. 14, Núm. 4, pp. 444-456

2020

  1. Bioresorbable vascular scaffold versus metallic drug-eluting stent in patients at high risk of restenosis: The COMPAREABSORB randomised clinical trial

    EuroIntervention, Vol. 16, Núm. 8, pp. 645-653

  2. Complete revascularization reduces cardiovascular death in patients with ST-segment elevation myocardial infarction and multivessel disease: systematic review and meta-analysis of randomized clinical trials

    European heart journal, Vol. 41, Núm. 42, pp. 4103-4110

  3. Management of myocardial revascularisation failure: An expert consensus document of the EAPCI

    EuroIntervention, Vol. 16, Núm. 11, pp. E875-E890

  4. Physiology-guided revascularization versus optimal medical therapy of nonculprit lesions in elderly patients with myocardial infarction: Rationale and design of the FIRE trial

    American Heart Journal, Vol. 229, pp. 100-109

2019

  1. Self-expandable sirolimus-eluting stents compared to second-generation drug-eluting stents for the treatment of the left main: A propensity score analysis from the SPARTA and the FAILS-2 registries

    Catheterization and Cardiovascular Interventions, Vol. 93, Núm. 2, pp. 208-215

2018

  1. Diagnostic performance of in-procedure angiography-derived quantitative flow reserve compared to pressure-derived fractional flow reserve: The FAVOR II Europe-Japan study

    Journal of the American Heart Association, Vol. 7, Núm. 14